We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

287 hedge funds and large institutions have $5.39B invested in United Therapeutics in 2013 Q2 according to their latest regulatory filings, with 287 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

134.59% more ownership

Funds ownership: 0% → 134.59% (+135%)

3% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $13.1M

Holders
287
Holders Change
+287
Holders Change %
–
% of All Funds
9.33%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
287
Increased
–
Reduced
–
Closed
–
Calls
$13.5M
Puts
$13.1M
Net Calls
+$400K
Net Calls Change
+$400K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

UTHR Hedge Fund Activity: Q2 2013 in Review

287 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2013, worth a combined $5.39B.

Buyers outnumbered sellers: 287 funds opened new UTHR positions and 0 closed out — a net gain of 287 holders — while 0 added to existing stakes and 0 trimmed.

  • 287 institutional investors held United Therapeutics (UTHR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.39B of United Therapeutics stock for Q2 2013.
  • 287 funds opened new United Therapeutics positions in Q2 2013 and 0 closed out, a net change of +287 holders.

Based on aggregated 13F filings for Q2 2013.